Cannabinoid Delivery Systems for Pain and Inflammation Treatment

​

Cannabidiol Reduces Intestinal Inflammation throughthe Control of Neuroimmune Axis

​

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

​

The endocannabinoid system: an emerging key player in inflammation

​

Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice

​

Cannabinoids, endocannabinoids, and related analogs in inflammation

​

Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor

​

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors

​

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis

​

Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation

​

Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement

​

Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption

​

Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation

​

Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death

​

Cannabinoids in clinical practice

​

CBD Absorption Rates for Pain and Inflammation Treatment